PCM
CNMD icon

Palouse Capital Management’s CONMED CNMD Stock Holding History

Palouse Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-7,880
Closed -$268K – 120
2013
Q3 		$268K Buy
7,880
+130
+2% +$4.24K 0.11% 108
2013
Q2 		$242K Buy
+7,750
New +$251K 0.1% 105

Other funds holding CNMD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Palouse Capital Management's CNMD Position: Q4 2013 in Review

Palouse Capital Management sold out of CONMED (CNMD) in Q4 2013, closing a stake of 7,880 shares — an estimated $268K sold.

Palouse Capital Management first reported a position in CNMD in Q2 2013 and held it in 2 quarters. The position peaked at $268K in Q3 2013. 155 funds tracked by Wall St. Rank hold CNMD as of Q4 2013.

  • Palouse Capital Management reported no remaining CONMED position as of Q4 2013 after selling out during the quarter.
  • Palouse Capital Management sold 7,880 CONMED shares in Q4 2013, an estimated $268K.
  • Palouse Capital Management first reported a position in CONMED in Q2 2013 and held it in 2 quarters.
  • Palouse Capital Management's CONMED position peaked at $268K in Q3 2013.
  • 155 funds tracked by Wall St. Rank held CONMED as of Q4 2013.

Based on Palouse Capital Management's 13F filing for Q4 2013, filed 31 Jan 2014.